Mycophenolate vs Azathioprin in Autoimmune Hepatitis
Mycophenolate vs Azathioprin in Autoimmune Hepatitis
A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10
 receiving mycophenolat mofetil.
Inclusion Criteria:

 -  De novo autoimmune hepatitis

 -  Consent

 Exclusion Criteria:

 -  age below 18

 -  pregnancy